TRCT
TYRA icon

Tower Research Capital (TRC)’s Tyra Biosciences TYRA Stock Holding History

Tower Research Capital (TRC)’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$115K Buy
3,005
+2,674
+808% +$86.6K ﹤0.01% 2074
2025
Q4 		$8.7K Sell
331
-543
-62% -$9.97K ﹤0.01% 3938
2025
Q3 		$12.2K Sell
874
-1,966
-69% -$22.4K ﹤0.01% 3809
2025
Q2 		$27.2K Buy
2,840
+757
+36% +$7.19K ﹤0.01% 3478
2025
Q1 		$19.4K Buy
2,083
+666
+47% +$8.62K ﹤0.01% 3000
2024
Q4 		$19.7K Buy
1,417
+206
+17% +$3.74K ﹤0.01% 3196
2024
Q3 		$28.5K Sell
1,211
-966
-44% -$20.3K ﹤0.01% 3034
2024
Q2 		$34.8K Buy
2,177
+2,033
+1,412% +$35K ﹤0.01% 3374
2024
Q1 		$2.36K Sell
144
-860
-86% -$14.1K ﹤0.01% 5059
2023
Q4 		$13.9K Buy
1,004
+146
+17% +$1.89K ﹤0.01% 3924
2023
Q3 		$11.8K Buy
858
+200
+30% +$2.97K ﹤0.01% 3955
2023
Q2 		$11.2K Sell
658
-888
-57% -$12.9K ﹤0.01% 4004
2023
Q1 		$25K Sell
1,546
-347
-18% -$4.13K ﹤0.01% 3219
2022
Q4 		$14K Sell
1,893
-2,310
-55% -$16.3K ﹤0.01% 3539
2022
Q3 		$37K Buy
4,203
+1,266
+43% +$11.6K ﹤0.01% 3440
2022
Q2 		$21K Buy
2,937
+1,694
+136% +$13.5K ﹤0.01% 3762
2022
Q1 		$13K Buy
1,243
+280
+29% +$3.32K ﹤0.01% 4003
2021
Q4 		$14K Buy
+963
New +$19.1K ﹤0.01% 4110

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Tower Research Capital (TRC)'s TYRA Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Tyra Biosciences (TYRA) stake by 808% in Q1 2026, buying an estimated $86.6K and bringing the position to 3,005 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #2074.

Tower Research Capital (TRC) first reported a position in TYRA in Q4 2021 and has held it in 18 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Tower Research Capital (TRC) held 3,005 shares of Tyra Biosciences worth $115K as of Q1 2026.
  • Tower Research Capital (TRC) bought 2,674 Tyra Biosciences shares in Q1 2026, an estimated $86.6K.
  • Tyra Biosciences made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2074 holding.
  • Tower Research Capital (TRC) first reported a position in Tyra Biosciences in Q4 2021 and has held it in 18 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.